Companies

Ozone Group to scale up consumer product biz

Meenakshi Verma Ambwani New Delhi | Updated on January 10, 2018

Teams up with Brazil’s Embelleze to enter hair-care segment



Delhi-based Ozone Group plans to scale up its consumer products business in the next three-to-five years. It is eyeing future growth from segments such as beauty, eyecare, pain management and women hygiene.

On Friday, the company also announced its partnership with Brazil’s Embelleze to foray into the professional hair care segment. The company had sold its successful skincare brand Nomarks to Bajaj Corp in 2013.

Talking about the company’s future plans, SC Sehgal, Chairman & MD, Ozone Group, said: “We have a pipeline of four-to-five brands and we believe there is potential to scale these up. These brands are in the categories of beauty, eyecare, pain management and women hygiene. These will be OTX, which will be a combination of prescription and over-the-counter products.”

The company’s current turnover is about ₹200 crore. A big chunk of its revenues come from its pharmaceuticals business, which it aims to grow at 25-30 per cent year-on-year. “We have aggressive plans to grow our overall turnover to ₹1,000 crore in the next three to five years.” he added.

The company will also be leveraging on its association with Embelleze, Brazil, to distribute a range of professional hair care products under brands Novex and Nutrisalon. These will be sold to salons and include shampoos, conditioners, hair spas and hair treatment products. The company already has presence in the professional skin care segment.

Sehgal said these products will initially be imported. “This is just the first step in our partnership. We could look at extending this association to a joint venture partnership in the future. We could look at making these products in India once we achieve scalable volumes,” he added.

Published on September 01, 2017

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor